165 related articles for article (PubMed ID: 159513)
1. Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
Hijikata A; Okamoto S; Kikumoto R; Tamao Y
Thromb Haemost; 1979 Oct; 42(3):1039-45. PubMed ID: 159513
[TBL] [Abstract][Full Text] [Related]
2. Serine protease specificity for peptide chromogenic substrates.
Mattler LE; Bang NU
Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
[TBL] [Abstract][Full Text] [Related]
3. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
Yomtova VM; Stambolieva NA; Blagoev BM
Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
[TBL] [Abstract][Full Text] [Related]
4. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinases.
Collen D; Lijnen HR; De Cock F; Durieux JP; Loffet A
Biochim Biophys Acta; 1980 Sep; 615(1):158-66. PubMed ID: 6448639
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
6. Proton inventory studies of alpha-thrombin-catalyzed reactions of substrates with selected P and P' sites.
Enyedy EJ; Kovach IM
J Am Chem Soc; 2004 May; 126(19):6017-24. PubMed ID: 15137766
[TBL] [Abstract][Full Text] [Related]
7. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
8. Steady-state kinetics of plasmin- and trypsin-catalysed hydrolysis of a number of tripeptide-p-nitroanilides.
Christensen U; Ipsen HH
Biochim Biophys Acta; 1979 Aug; 569(2):177-83. PubMed ID: 38847
[TBL] [Abstract][Full Text] [Related]
9. New fluorogenic peptide substrates for plasmin.
Kato H; Adachi N; Ohno Y; Iwanaga S; Takada K; Sakakibara S
J Biochem; 1980 Jul; 88(1):183-90. PubMed ID: 6447693
[TBL] [Abstract][Full Text] [Related]
10. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
11. Development of plasma kallikrein selective inhibitors.
Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
[TBL] [Abstract][Full Text] [Related]
12. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
Walker B; Elmore DT
Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
Lijnen HR; Uytterhoeven M; Collen D
Thromb Res; 1984 Jun; 34(5):431-7. PubMed ID: 6234678
[TBL] [Abstract][Full Text] [Related]
14. [p-Nitroanilides of amino acids and peptides and fluorescence peptide with inner fluorescence quenching as substrates for cathepsins H, B, D and high molecular weight aspartic peptidase in the brain].
Azarian AV; Agatian GL; Galoian AA
Biokhimiia; 1987 Dec; 52(12):2033-7. PubMed ID: 3328984
[TBL] [Abstract][Full Text] [Related]
15. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
16. New chromogenic substrates for thrombin with increased specificity.
Kolde HJ; Eberle R; Heber H; Heimburger N
Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
[TBL] [Abstract][Full Text] [Related]
17. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-L-prolylglycyl-L-arginine 4-nitroanilide.
Ipsen HH; Christensen U
Biochim Biophys Acta; 1980 Jun; 613(2):476-81. PubMed ID: 6449958
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivatives.
Lewis SD; Ng AS; Lyle EA; Mellott MJ; Appleby SD; Brady SF; Stauffer KJ; Sisko JT; Mao SS; Veber DF
Thromb Haemost; 1995 Oct; 74(4):1107-12. PubMed ID: 8560421
[TBL] [Abstract][Full Text] [Related]
19. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.
Morita T; Kato H; Iwanaga S; Takada K; Kimura T
J Biochem; 1977 Nov; 82(5):1495-8. PubMed ID: 591514
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
